Abstract:The group of AGC protein kinases includes more than 60 protein kinases in the human genome (e.g. PDK1 and isoforms of PKA, PKC, PRK, PKB/Akt, S6K, SGK, RSK, MSK, ROCK, GRK, amongst others). This group is also widely represented in other eukaryotes, including organisms that cause human infectious diseases. Human AGC kinases are involved in diverse cellular functions and are potential targets for the treatment of cancer, diabetes, obesity, neurological disorders, inflammation, viral infections, etc. Small molecule inhibitors of AGC kinases can also be considered as potential candidates for the development of targeted therapies against infectious diseases. AGC kinases are typically regulated by phosphorylation at three sites, the activation loop, the Zipper/turn-motif and the hydrophobic motif sites, and by other diverse mechanisms including intramolecular interactions with other regions of the protein, oligomerization, interaction with regulatory subunits, and second messengers. Interestingly, we were able to identify that a particular pocket on the kinase domain, termed the PIF-pocket, is a key mediator of the allosteric regulation of many AGC kinases. We first described the regulatory properties of the PIF-pocket on PDK1 [1]. Follow-up work verified that the PIF-pocket is also the key site that mediates the activation by Zipper/ turn-motif and hydrophobic motif phosphorylation of PKB/Akt, S6K, RSK, SGK, PKC, PRK, and MSK [2–4]. Interaction with the PIF-pocket also regulates the intramolecular inhibition of atypical PKCs by their N-terminal domains [5] and the oligomerization that inhibits PRK2 [6]. Moreover, we have developed reversible low-molecular-weight compounds that, by targeting the PIF-pocket site, allosterically activate PDK1 [7, 8], or allosterically inhibit atypical PKCs [5]. Our studies have shed light on the molecular details of the mechanism of allosteric regulation by small compounds and support the future development of drugs directed to the PIF-pocket of AGC kinases. The PIF-pocket regulatory site shares similar features with a dimerization regulatory site recently discovered on receptor tyrosine kinases, suggesting that the deep Invited Lectures

The Study Of Digitoflavone For The Inhibition Of Protein Kinase Ck2 In Hl-60 Cells

Inhibitory Effect of Kaempferol on Protein Kinase CK2 in vitro and in HL-60 Cells

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

Digitoflavone Inhibits IκBα Kinase and Enhances Apoptosis Induced by TNFα Through Downregulation of Expression of Nuclear Factor Κb-Regulated Gene Products in Human Pancreatic Cancer Cells

Structure-activity Relationship of 7 Flavonoids on Recombinant Human Protein Kinase CK2 Holoenzyme

Inhibitory Effect and Kinetic Analysis of 1,8-Dihydroxyanthraquinone on Recombinant Human Protein Kinase CK2 Holoenzyme

[Inhibitory Effect and Kinetic Analysis of Sodium Quercetin-7,4'-disulphate on Recombinant Human Protein Kinase CK2 Holoenzyme].

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Inhibitory Effect and Its Kinetic Analysis of Tyrphostin AG1478 on Recombinant Human Protein Kinase CK2 Holoenzyme.

[Inhibitory Effect and Its Kinetic Analysis of Baicalein on Recombinant Human Protein Kinase CK2 Holoenzyme].

[Inhibitory Effect of AG1109 on Recombinant Human Protein Kinase CK2 Holoenzyme].

Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin

[Effects of Mitoxantrone on the Activity of Human Protein Kinase CK2 Holoenzyme].

Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.

Inhibitory effect of luteolin on recom- binant human protein kinase CK2 holoenzyme in vitro

Naturally Occurring Homoisoflavonoids As Potent Protein Tyrosine Kinases Inhibitors

Cimicifugoside H-2 as an Inhibitor of IKK1/Alpha: A Molecular Docking and Dynamic Simulation Study

Discovery of Novel Naphthoquinone Derivatives As Inhibitors of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase.

L 2 The curious case of the inhibition of the p 90 ribosomal S 6 kinase by a plant flavonol glycoside , SL 0101

Virtual Screening, Molecular Dynamics, and Mechanism Study of Homeodomain-Interacting Protein Kinase 2 Inhibitor in Renal Fibroblasts

Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia